# Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma

> **NCT00861185** · PHASE2 · COMPLETED · sponsor: **Icagen** · enrollment: 69 (actual)

## Conditions studied

- Exercise Induced Asthma

## Interventions

- **DRUG:** senicapoc
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00861185
- **Lead sponsor:** Icagen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-07
- **Final completion:** 2009-09
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2011-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861185, "Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00861185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*